Office of Research

Artificial Intelligence and Technology Collaboratory (P30 Clinical Trial Optional)

Limited Submissions

This Notice of Funding Opportunity (NOFO) invites Center Core (P30) applications for the National Institute on Aging's (NIA) Artificial Intelligence and Technology Collaboratories (AITC) program. The AITC program promotes the development and implementation of artificial intelligence (AI) approaches and technology through research projects for aging and Alzheimer's Disease (AD) and AD-related dementias (ADRD) research. All applications should propose strategies for addressing challenges surrounding AI and technology development and implementation, and to employ, when possible, best practices established in the fields of aging and AD/ADRD.

The AITC Program supports innovative cross-disciplinary collaborative teams, with investigators from academia, non-profit, and healthcare sectors across a wide range of disciplines working to advance priorities in aging and AD/ADRD research.

Goals of the overall AITC Program are as follows:

  1. Serve as a national resource to promote development and implementation of innovative AI and technology approaches to advance aging and AD/ADRD priorities;
  2. Support nationwide research projects to develop and implement AI and technology approaches and respond rapidly to emerging priorities in the shifting AI and technology landscape; and
  3. Collaborate with a wide range of stakeholders in addressing algorithmic fairness and how to incorporate AI and technology approaches in the special circumstances of individuals experiencing cognitive decline/impairment.

In achieving these goals, it is expected that the Collaboratories will interact with each other and with the AITCC. The AITCC will serve as a hub for the AITC Program and will facilitate and coordinate activities across Collaboratories. The AITCC will also facilitate a centralized program-wide Stakeholder Engagement Team to ensure that AI approaches and technologies developed by the Collaboratories will be maximally adoptable by and accessible to their end users by soliciting stakeholder input throughout all phases of the development cycle.

Application Instructions

Please submit as one combined pdf labeled with PI’s Lastname, Firstname:

  1. A one‐page letter of intent with a description of proposed aims and approach.
  2. If the final application requires a statement of broader impacts, please summarize your plans to address the specific requirements on an additional page.
  3. CV (not biosketch) of the PI including past grant funding.

to limitedsubs@uw.edu by 5:00 PM Tuesday, September 30, 2025. Proposals are due to the sponsor 10/15/2025 so you will need to have your materials in to the Office of Sponsored Programs by 10/6/2025 if given the go‐ahead by the Limited Submissions review committee.

Opportunity Details

Program web page

Program Announcement No.

RFA-AG-26-006

Deadlines
09/30/2025 UW Internal Deadline Closed
10/06/2025 OSP Deadline
10/15/2025 Sponsor Deadline
Sponsor

National Institutes of Health (NIH)

Funding amount

$4,000,000 (in direct costs per year for 5 years)

Maximum Number of Applications

1

Eligible groups
  • All campus

Inquiries and Contact Information

Investigators who identify a grant, award or fellowship program that restricts the number of applications that can be submitted from an Institution should immediately contact their Chairperson, Associate Dean for Research (or Dean, if no ADR) and the Office of Research (see below) if they intend to prepare a response. Failure to do so, or to meet the deadlines for submission of pre-proposal, will preclude submission of the application through the Office of Sponsored Programs.

For general inquiries, or to request a listing of a limited submission opportunity that should be but is not already listed, please email us at limitedsubs@uw.edu.